Mononeuropathy multiplex in association with livedoid vasculitis

Muscle and Nerve

Volumn 28, Issue 5, 2003, Pages 634-639

  Toth, Cory ^a   Trotter, Martin ^a   Clark, Arthur ^a   Zochodne, Douglas ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Livedoid vasculitis; Mononeuropathy multiplex; Vasculopathy

Indexed keywords

FIBRIN; THROMBIN;

ADULT; ARTICLE; BLOOD VESSEL; CASE REPORT; CHRONIC DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; HYPERCOAGULABILITY; HYPERPIGMENTATION; ISCHEMIA; MONONEUROPATHY MULTIPLEX; PERIPHERAL NERVOUS SYSTEM; PETECHIA; PRIORITY JOURNAL; SEGMENTED HYALINIZING VASCULITIS; SKIN DISEASE; SKIN ULCER; VASCULAR DISEASE;

ADULT; ANKLE; FEMALE; HUMANS; MONONEUROPATHIES; NEURONS, AFFERENT; SKIN DISEASES, VASCULAR; VASCULITIS;

EID: 0242363192     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.10450     Document Type: Article

References (45)

1. Acland KM, Darvay A, Wakelin SH, Russell-Jones R. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome? Br J Dermatol 1999;140:131-135.
2. Baccard M, Vignon-Pennamen MD, Janier M, Scrobohaci ML, Dubertret L. Livedo vasculitis with protein C system deficiency. Arch Dermatol 1992;128:1410-1411.
3. Bard JW, Winkelmann RK. Livedo vasculitis: segmental hyalinizing vasculitis of the dermis. Arch Dermatol 1967;96:489-499.
4. Boyvat A, Kundakci N, Babikir MO, Gurgey E. Livedoid vasculopathy associated with heterozygous protein C deficiency. Br J Dermatol 2000;143:840-842.
5. Calamia KT, Balabanova M, Perniciaro C, Walsh JS. Livedo (livedoid) vasculitis and the factor V Leiden mutation: additional evidence for abnormal coagulation. J Am Acad Dermatol 2002;46:133-137.
6. Champion RH. Livedo reticularis with recurrent ulceration treated with anticoagulants. Br J Dermatol 1962;74:195-196.
7. Choi HJ, Hann SK. Livedo reticularis and livedoid vasculitis responding to PUVA therapy. J Am Acad Dermatol 1999;40: 204-207.
8. Drucker CR, Duncan WC. Antiplatelet therapy in atrophie blanche and livedo vasculitis. J Am Acad Dermatol 1982;7: 359-363.
9. Ely H, Bard JW. Therapy of livedo vasculitis with pentoxifylline. Cutis 1988;42:448-453.
10. Gibson GE, Li H, Pittelkow MR. Homocysteinemia and livedoid vasculitis. J Am Acad Dermatol 1999;40:279-281.
11. Gillam JN, Herndon JH, Prystowsky SD. Fibrinolytic therapy for vasculitis of atrophie blanche. Arch Dermatol 1974;109: 664-667.
12. Gjessing HC, Dedichen J. Livedo reticularis with summer ulcerations: report of a case treated with long-term anticoagulant therapy. Acta Med Scand 1956;319:74-78.
13. Grisold W, Drlicek M, Hitzenberger P, Jellinger K, Liszka U, Paternostro T. Paraneoplastic sensory neuropathy. In: Asbury AK, Budka H, Sluga E, editors. Sensory neuropathies. New York: Springer; 1995. p 173-181.
14. Grob JJ, Bonerandi JJ. Thrombotic skin disease as a marker of the anticardiolipin syndrome. Livedo vasculitis and distal gangrene associated with abnormal serum antiphospholipid activity. J Am Acad Dermatol 1989;20:1063-1069.
15. Hegemann B, Helmbold P, Marsh, WC. Livedoid vasculitis with ulcerations: the role of antithrombin III deficiency and its therapeutic consequences. Arch Dermatol 2002;138:841-8422.
16. Hoogenberg K, Tupker RA, Van Essen LH, Smit AL, Kallenberg CGM. Successful treatment of ulcerating livedo reticularis with infusion of prostacyclin. Br J Dermatol 1992;127: 64-66.
17. Hsiao GH, Chiu HC. Livedoid vasculitis: response to low-dose danazol. Arch Dermatol 1996;32:749-751.
18. Jacobson RR, Krahenbuhl JL. Leprosy. Lancet 1999;353:655-660.
19. Jetton RL, Lazarus GS. Minidose heparin therapy for vasculitis of atrophie blanche. J Am Acad Dermatol 1983;8:23-26.
20. Kern AB. Atrophie blanche: report of two patients treated with aspirin and dipyridamole. J Am Acad Dermatol 1982;6: 1048-1053.
21. Klein KL, Pittelkow MR. Tissue plasminogen activator for treatment of livedoid vasculitis. Mayo Clinic Proc 1992;67: 923-933.
22. Lee JH, Choi HJ, Kim SM, Hann SK, Park YK. Livedoid vasculitis responding to PUVA therapy. Int J Dermatol 2001; 40:153-157.
23. Matthews WB, Esiri M. The migrant sensory neuritis of Wartenberg. J Neurol Neurosurg Psychiatry 1983;46:1-4.
24. Matthews WB, Squier MV. Sensory perineuritis. J Neurol Neurosurg Psychiatry 1988;51:473-475.
25. McCalmont CS, Mc Calmont TH, Jorizzo JL, White WL, Leshin B, Rothberger H. Livedo vasculitis: vasculitis or thrombotic vasculopathy? Clin Exp Dermatol 1992;17:4-8.
26. Mitsumoto H, Wilbourn AJ. Causes and diagnosis of sensory neuropathies: a review. J Clin Neurophysiol 1994; 11: 553-567.
27. Nicolle MW, Barron JR, Watson BV, Hammond RR, Miller TA. Wartenberg's migrant sensory neuritis. Muscle Nerve 2001;24:438-443.
28. Ooi C, Dayan L. Syphilis. Diagnosis and management in general practice. Aust Fam Physician 2002;31:629-635.
29. Pizzo SV, Murray JC, Gonias SL. Atrophie blanche: a disorder associated with defective release of tissue plasminogen activator. Arch Pathol Lab Med 1986;110:517-519.
30. Ravat FE, Evans AV, Russell-Jones R. Response of livedoid vasculitis to intravenous immunoglobulin. Br J Dermatol 2002;147:166-169.
31. Rubin M, Mackenzie CR. Clinically and electrodiagnostically pure sensory demyelinating polyneuropathy. Electromyogr Clin Neurophysiol 1996;36:145-149.
32. Rustin MHA, Bunker CB, Dowd PM. Chronic leg ulceration with livedoid vasculitis, and response to oral ketanserin. Br J Dermatol 1989;120:101-105.
33. Sams WM. Livedo vasculitis: therapy with pentoxifylline. Arch Dermatol 1988;124:684-687.
34. Sauer GC. Pentoxifylline (Trental) therapy for the vasculitis of atrophie blanche. Arch Dermatol 1986;122:380-381.
35. Smith BE. Inflammatory sensory polyganglionopathies. Neurol Clin 1992;10:735-759.
36. Tran MD, Becherel PA, Cordel N, Piette JC, Frances C. "Idiopathic" white atrophy. Ann Dermatol Venereol 2001;128: 1003-1007.
37. Tsutsui K, Shirasaki F, Takata M, Takehara K. Successful treatment of livedo vasculitis with beraprost sodium: a possible mechanism of thrombomodulin upregulation. Dermatology 1996;192:120-124.
38. Wakelin SH, Ellis JP, Black MM. Livedoid vasculitis with anti-cardiolipin antibodies: improvement with danazol. Br J Dermatol 1998;139:935-937.
39. Wartenberg R. Main clinical features of sensory neuritis. In: Neuritis, sensory neuritis, neuralgia. A clinical study with review of the literature. New York: Oxford University Press; 1958. p 248-254.
40. Wartenberg R. Migrant sensory neuritis. In: Neuritis, sensory neuritis, neuralgia. A clinical study with review of the literature . New York: Oxford University Press; 1958. p 233-247.
41. Windebank AJ, Blexrud MD, Dyck PJ, Daube JR, Karnes JL. The syndrome of acute sensoD' neuropathy: clinical features and electrophysiologic and pathologic changes. Neurology 1990;40:584-591.
42. Winkelmann RK, Schroeter AL, Kierland RR, Ryan TM. Clinical studies of livedoid vasculitis: (segmental hyalinizing vasculitis). Mayo Clin Proc 1974;49:746-750.
43. Yasue T. Livedoid vasculitis and central nervous system involvement in systemic lupus erythematosus. Arch Dermatol 1986;122:66-70.
44. Yuki N, Miyatani N, Sato S, Hirabayashi Y, Yamazaki M, Yoshimura N, Hayashi Y, Miyatake T. Acute relapsing sensory neuropathy associated with IgM antibody against B-series gangliosides containing a Ga1NAcB1-4(Ga13-2aNeuAc8-2aNeuAc)B1 configuration. Neurology 1992;42:686-689.
45. Zifko UA, Hahn AF. Migrant sensory neuropathy: report of 5 cases and review of the literature. J Periph Nerv Syst 1997;2: 244-249.